SCHEMBL6914541

SCHEMBL6914541

Cc1cc(CCc2ccc(=O)[nH]n2)n(C)c1C(=O)c1ccc(Cl)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 1/20 0.57
PTGS2 P35354 1/20 0.57
CYP1A2 P05177 4/20 0.54
LMNA P02545 3/20 0.54
ALDH1A1 P00352 3/20 0.54
TSHR P16473 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
MAPT P10636 5/20 0.39
CYP2C9 P11712 4/20 0.39
CYP2C19 P33261 3/20 0.39
CYP2D6 P10635 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
GFER P55789 1/20 0.35
HDAC3 O15379 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
CYP3A4 P08684 1/20 0.34
HTT P42858 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2128672 0.90 ABCB11 (0.58) ABCB11PTGS2CYP1A2LMNAALDH1A1
SCHEMBL8293709 0.81 PTGS2 (0.46) ABCB11PTGS2CYP1A2LMNAALDH1A1
SCHEMBL8904523 0.81 ABCB11 (0.45) ABCB11PTGS2CYP1A2LMNAALDH1A1
SCHEMBL8907117 0.80 ABCB11 (0.58) ABCB11PTGS2CYP1A2LMNAALDH1A1
SCHEMBL8905945 0.80 ABCB11 (0.44) ABCB11PTGS2CYP1A2LMNAALDH1A1
SCHEMBL8905879 0.80 ABCB11 (0.44) ABCB11PTGS2CYP1A2LMNAALDH1A1
SCHEMBL8905668 0.79 ABCB11 (0.46) ABCB11PTGS2CYP1A2LMNAALDH1A1
SCHEMBL27370570 0.79 ABCB11 (0.57) ABCB11PTGS2CYP1A2LMNAALDH1A1
SCHEMBL8906143 0.79 ABCB11 (0.43) ABCB11PTGS2CYP1A2LMNAALDH1A1
SCHEMBL9030442 0.78 ABCB11 (0.42) ABCB11PTGS2CYP1A2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1435956-A2 THERAPEUTIC COMBINATIONS FOR CARDIOVASCULAR AND INFLAMMATORY INDICATIONS Pharmacia Corporation (US) 2004-07-14 EP claimed
WO-2002078626-A2 THERAPEUTIC COMBINATIONS FOR CARDIOVASCULAR AND INFLAMMATORY INDICATIONS PHARMACIA CORPORATION (US) 2002-10-10 WO claimed
EP-1435956-A2 THERAPEUTIC COMBINATIONS FOR CARDIOVASCULAR AND INFLAMMATORY INDICATIONS Pharmacia Corporation (US) 2004-07-14 EP disclosed
WO-2002078626-A2 THERAPEUTIC COMBINATIONS FOR CARDIOVASCULAR AND INFLAMMATORY INDICATIONS PHARMACIA CORPORATION (US) 2002-10-10 WO disclosed